Patents
Patents for C07D 515 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups , or (877)
07/2007
07/11/2007EP1805144A1 Heterocyclical chromophore architectures
07/10/2007US7241892 Hemisynthetic method and new compounds
07/05/2007WO2007075194A1 Selective benzylamine derivatives and their utility as cholesterol ester-transfer protein inhibitors
07/05/2007WO2006069080A3 Pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2m3-b]pyrimidin-4-yl-amines as janus kinase inhibitors
07/05/2007CA2642130A1 Selective benzylamine derivatives and their utility as cholesterol ester-transfer protein inhibitors
06/2007
06/21/2007US20070142310 treating Human Immuno-Deficiency Virus (HIV); nucleoside or nucleotide analogues; RNA viral diseases; anticarcinogenic agents treating hematopoetic cancers
05/2007
05/29/2007US7223866 Imidazo[1,5-a]pyridine derivatives and methods for treating aldosterone mediated diseases
05/24/2007US20070117799 Oxabispidine compounds useful in the treatment of cardiac arrhythmias
05/22/2007US7220859 For use in therapy
05/22/2007US7220738 Rifamycin analogs and uses thereof
05/16/2007EP1784186A2 Methods for treating or preventing erectile dysfunction or urinary incontinence
04/2007
04/26/2007US20070093658 used for the treatment of a cancer in mammals; anticarnogenic or antitumor agents
04/10/2007US7202361 Antitumoral ecteinascidin derivatives
03/2007
03/21/2007CN1934116A Tricyclic benzopyran compound as anti-arrhythmic agents
03/13/2007US7189851 Condensed heterocyclic compounds as calcitonin agonists
03/07/2007CN1923835A Polymorphs of clopidogrel hydrogensulfate
02/2007
02/08/2007US20070032640 Cytokine receptor
01/2007
01/18/2007WO2007007399A1 Thiazole compound
01/17/2007CN1896064A Metabolites of ecteinascidin 743
01/16/2007US7164017 Exhibit electrophysiological activity
12/2006
12/20/2006EP1732929A1 Tricyclic benzopyran compound as anti-arrhythmic agents
12/12/2006CA2266081C Process for producing ecteinascidin compounds
12/07/2006WO2006130673A1 3-benzoimidazolyl-pyrazolopyridines useful in treating kinase disorders
11/2006
11/22/2006EP1530574B1 Macrocyclic pyrimidines, the production thereof and the use of the same as medicaments
11/02/2006EP1716853A2 Treatment of cancers of the human body using ET743
10/2006
10/26/2006WO2006065448A3 Topoisomerase inhibitors and prodrugs
10/24/2006US7125886 2-imidazomethyl- pyrido(4,3-b)indol-1-one or -carbazol-1-one derivatives containing an ester group; especially for treating irritable bowel syndrome.
10/17/2006US7122081 Reducing particle size of organic pigments by milling the crude pigment in the presence of a water soluble styrene copolymer dispersant, optionally a defoamer, optionally an additive, and greater than about 10 wt. % water, and isolating the organic pigment
10/05/2006WO2006103088A1 Novel hydroxyethylamine and ketone compounds having asp2 inhibitory activity
10/03/2006US7115743 For treatment of leukemia, carcinomas, adenocarcinomas, and melanoma; assaying metabolism via cytochromes
09/2006
09/27/2006CN1837217A 4-substituted heterocyclo thiadiazine derivatives and process for preparing same
09/27/2006CN1837216A Process for preparing 2,4-disubstituted heterocyclo [4,5-e][1,2,4] thiadiazine derivatives
09/20/2006EP1702618A2 Compositions and uses of ET743 in combination therapy for cancer treatment
09/20/2006CN1835749A 有丝分裂驱动蛋白抑制剂 Mitotic kinesin inhibitors
09/19/2006US7109340 Substituted tetrahydro-1H-pyrazolo [3,4-c] pyridines, compositions comprising them, and use
09/19/2006US7109233 substituted 1,1,4-1l6-trioxo[1,2]thiazepan-4-ylamide-derived protease inhibitors which inhibit the likes of cathepsin K; treating osteoporosis, osteo- and rheumatoid arthritis and periodontal disease; inhibiting excessive cartilage or matrix degradation
09/12/2006US7105660 Intramolecular amidation of sulfamates catalyzed by metalloporphyrins
09/06/2006EP1697382A2 Rifamycin analogs and uses thereof
09/06/2006EP1176964B1 Uses of et743 for treating cancer
09/05/2006US7101428 stability of gamma-quinacridone pigment during milling by addition of 2,9-dichloroquinacridone
08/2006
08/24/2006WO2006088191A1 Eudistomin derivative
08/24/2006WO2006078891A3 Imidazolylmethyl and pyrazolylmethyl heteroaryl derivatives
08/24/2006WO2004094374A3 Preparation of (s)-clopidogrel and related compounds
08/16/2006EP1689746A2 A process for aqueous milling of quinacridone pigments
07/2006
07/27/2006US20060166980 New oxabispidine compounds useful in the treatment of cardiac arrhythmias
07/27/2006US20060166979 for prophylaxis and treatment of atrial and ventricular arrhythmias
07/19/2006CN1805965A Heterocyclic cyclopentyl tetrahydroisoquinoline and tetrahydropyridopyridine modulators of chemokine receptor activity
07/12/2006EP1335923B1 Condensed pyridoindole derivatives
07/04/2006US7071336 Process for manufacturing opioid analgesics
06/2006
06/29/2006CA2592119A1 Pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2,3-b]pyrimidin-4-yl-amines as janus kinase inhibitors
06/27/2006US7067666 7-substituted camptothecin and camptothecin analogs and methods for producing the same
06/15/2006US20060128711 derivatives of ecteinascidins, particularly ecteinascidin 736, used for the treatment of lung, colon, kidney, prostate, cervical, ovarian, breast or pancreatic cancer, leukaemia or melanoma in mammals; reduced systemic toxicity and improved pharmacokinetics
06/14/2006EP1668985A2 Nucleophile substituted ecteinascidins and N-oxide ecteinascidins
06/13/2006US7060828 Angiogenosis inhibitor; anticancer agents
05/2006
05/31/2006CN1257908C Benzoxazepine derivatives and their use as AMPA receptor stimulators
05/30/2006US7053211 Process for the preparation of α-aminosubstituted carboxylic acid amides
05/18/2006US20060106021 ecteinascidins used for treating lung, colon, kidney, prostate, ovarian, breast and pancreatic cancers, leukaemia or melanoma
05/17/2006EP1656140A1 Mitotic kinesin inhibitors
05/11/2006WO2006050435A1 Heterocyclical chromophore architectures
05/11/2006CA2584869A1 Heterocyclical chromophore architectures
05/02/2006US7037920 Substituted tricyclic himbacine derivatives that are useful as thrombin receptor antagonists
04/2006
04/13/2006US20060079677 Novel tricyclic azepine derivatives, method for production thereof and pharmaceutical compositions comprising the same
04/04/2006CA2262745C Highly lipophilic camptothecin derivatives
03/2006
03/08/2006CN1745087A Novel tricyclic azepine derivatives, method for production therof and pharmaceutical compositions comprising the same
02/2006
02/23/2006US20060041136 alpha-(2-chlorophenyl)-6,7dihydrothieno[3,2-c]pyridine-5(4H)-acetic acid methyl ester (clopidogrel hydrogen sulphate); separating crystalline form out of a solution of clopidogrel in the form of the free base in a 2-propanol or n-butyl acetate solvent by adding sulphuric acid
02/15/2006CN1242052C Biological pure culture for Nocardia
02/09/2006US20060030571 Ecteinascidins
02/08/2006EP1622916A2 Heterocyclic cyclopentyl tetrahydroisoquinoline and tetrahydropyridopyridine modulators of chemokine receptor activity
01/2006
01/26/2006US20060019960 Antitumoral analogs of ET-743
01/26/2006US20060019959 Novel quinoxalinone derivatives
01/05/2006US20060004002 Small molecule thienopyrimidine-based protein tyrosine kinase inhibitors
12/2005
12/22/2005WO2005058231A3 Rifamycin analogs and uses thereof
11/2005
11/30/2005CN1229382C Hemisynthetic method and intermediate thereof
11/24/2005US20050261326 Metabolites of ecteinascidin 743
11/02/2005EP1590355A1 Novel tricyclic azepine derivatives, method for production therof and pharmaceutical compositions comprising the same
10/2005
10/19/2005CN1683299A Metabolites of ecteinascidin 743
10/12/2005CN1679631A Compositions and uses of et743 for treating cancer
10/11/2005CA2373794C Compositions and uses of et743 for treating cancer
09/2005
09/29/2005WO2005090357A1 Tricyclic benzopyran compound as anti-arrhythmic agents
09/13/2005US6942966 Methods for processing chemical compounds having reactive functional groups
09/07/2005EP1569942A2 Tricyclic aminocyanopyridine inhibitors of mitogen activated protein kinase-activated protein kinase-2
08/2005
08/25/2005US20050187313 Process for aqueous milling of quinacridone pigments
08/25/2005US20050183635 stability of gamma-quinacridone pigment during milling by addition of 2,9-dichloroquinacridone
08/10/2005EP1345946B1 Macroheterocylic compounds useful as kinase inhibitors
08/04/2005WO2005049735A3 A process for aqueous milling of quinacridone pigments
08/03/2005EP1559717A2 Oxabispidine compounds useful in the treatment of cardiac arrythmias
07/2005
07/27/2005EP1557418A1 Novel quinoxaline derivatives
07/27/2005EP1287004B1 Synthetic process for the manufacture of an ecteinascidin compound
07/27/2005CN1646539A The synthesis of naturally occuring ecteinascidins and related compounds
07/20/2005EP1554284A1 Method for manufacturing crystalline form i of clopidogrel hydrogen sulphate
07/20/2005CN1211386C Antitumoral analogue of Et-743
07/06/2005EP1280809B1 Antitumoral ecteinascidin derivatives
06/2005
06/30/2005WO2005058231A2 Rifamycin analogs and uses thereof
06/30/2005CA2549001A1 Rifamycin analogs and uses thereof
06/29/2005EP1545558A2 1, 3, 5-triazines for treatment of viral diseases
06/23/2005US20050137189 For therapy of Gram-positive bacterial infection
06/02/2005WO2005049735A2 A process for aqueous milling of quinacridone pigments
05/2005
05/25/2005CN1620293A Polymorphs of clopidogrel hydrogensulfate
04/2005
04/13/2005CN1606449A Improved use of antitumoral compound in cancer therapy
04/12/2005CA2259721C Cyclic aryl ethers, thioethers and amines, and method for preparation
1 2 3 4 5 6 7 8 9